Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells

Sato,Ryuta; Yamasaki,Mutsushi; Hirai,Kenichi; Matsubara,Takanori; Nomura,Takeo; Sato,Fuminori; Mimata,Hiromitsu

doi:10.3892/or.2014.3586

Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells

Authors:
- Ryuta Sato
- Mutsushi Yamasaki
- Kenichi Hirai
- Takanori Matsubara
- Takeo Nomura
- Fuminori Sato
- Hiromitsu Mimata
View Affiliations

Affiliations: Department of Urology, Oita University Faculty of Medicine, Hasama, Yufu-city, Oita 879-5593, Japan
Published online on: November 3, 2014 https://doi.org/10.3892/or.2014.3586
Pages: 58-66
Copyright: © Sato et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiopoietin-like proteins (ANGPTLs), which comprise 7 members (ANGPTL1-ANGPTL7), structurally resemble angiopoietins. We investigated the roles of ANGPTLs in the acquisition of androgen independence and the malignant behavior of human prostate cancer cells. Expression of ANGPTL messenger RNA (mRNA) and proteins were ascertained using RT-qPCR and western blot analysis in human prostate cancer cell lines. Androgen‑dependent LNCaP and androgen-independent LNCaP/AI cells, respectively, were cultured in fetal bovine and charcoal-stripped medium. Cell proliferation, androgen dependence, migration and invasion, respectively, were examined under the overexpression and knockdown of ANGPTL2 by transfection of ANGPTL2 cDNA and its small‑interfering RNA (siRNA). The effects of exogenous ANGPTL2 and blocking of its receptor, integrin α5β1, were also investigated. Human prostate cancer cell lines predominantly expressed ANGPTL2 among the members. Interrupting ANGPTL2 expression with siRNA suppressed the proliferation, migration and invasion of LNCaP cells. LNCaP/AI cells showed a higher ANGPTL2 expression than that of LNCaP cells. Furthermore, siRNA led to apoptosis of LNCaP/AI cells. The ANGPTL2-overexpressing LNCaP cells markedly increased proliferation, epithelial-to-mesenchymal transition (EMT) and malignant behavior in androgen‑deprived medium. The migration rates were increased depending on the concentration of ANGPTL2 recombinant protein and were inhibited by anti-integrin α5β1 antibodies. To the best of our knowledge, this is the first study to elucidate the expression of ANGPTL2 in human prostate cancer cells. ANGPTL2 may be important in the acquisition of androgen independency and tumor progression of prostate cancer in an autocrine and/or paracrine manner via the integrin α5β1 receptor. Targeting ANGPTL2 may therefore be an efficacious therapeutic modality for prostate cancer.

View Figures

View References

1	Damber JE and Aus G: Prostate cancer. Lancet. 371:1710–1721. 2008. View Article : Google Scholar : PubMed/NCBI
2	Grönberg H: Prostate cancer epidemiology. Lancet. 361:1048–1053. 2003. View Article : Google Scholar
3	Scher HI, Buchanan G, Gerald W, et al: Targeting the androgen receptor: Improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer. 11:459–476. 2004. View Article : Google Scholar : PubMed/NCBI
4	Oike Y and Tabata M: Angiopoietin-like proteins. Circ J. 73:2192–2197. 2009. View Article : Google Scholar : PubMed/NCBI
5	Dhanabal M, LaRochelle WJ, Jeffers M, Herrmann J, et al: Angioarretin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res. 62:3834–3841. 2002.PubMed/NCBI
6	Kubota Y, Oike Y, Satoh S, et al: Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acad Sci USA. 102:13502–13507. 2005. View Article : Google Scholar : PubMed/NCBI
7	Camenisch G, Pisabarro MT, Sherman D, et al: ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem. 277:17281–17290. 2002. View Article : Google Scholar : PubMed/NCBI
8	Ito Y, Oike Y, Yasunaga K, et al: Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res. 63:6651–6657. 2003.PubMed/NCBI
9	Zeng L, Dai J, Ying K, et al: Identification of a novel human angiopoietin-like gene expressed mainly in heart. J Hum Genet. 48:159–162. 2003. View Article : Google Scholar : PubMed/NCBI
10	Oike Y, Yasunaga K, Ito Y, et al: Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration. Proc Natl Acad Sci USA. 100:9494–9499. 2003. View Article : Google Scholar
11	Katoh Y and Katoh M: Comparative integromics on Angiopoietin family members. Int J Mol Med. 17:1145–1149. 2006.PubMed/NCBI
12	Aoi J, Endo M, Kadomatsu T, et al: Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res. 71:7502–7512. 2011. View Article : Google Scholar : PubMed/NCBI
13	Endo M, Nakano M, Kadomatsu T, et al: Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res. 72:1784–1794. 2012. View Article : Google Scholar : PubMed/NCBI
14	Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 10:178–188. 2009. View Article : Google Scholar : PubMed/NCBI
15	Okada T, Tsukano H, Endo M, et al: Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol. 176:2309–2319. 2010. View Article : Google Scholar : PubMed/NCBI
16	Avraamidea CJ, Garmy-Susini B and Varner JA: Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer. 8:604–617. 2008. View Article : Google Scholar
17	Desgrosellier JS and Cheresh DA: Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 10:9–22. 2010. View Article : Google Scholar
18	Kikuchi R, Tsuda H, Kozaki K, et al: Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein2, in ovarian cancer. Cancer Res. 68:5067–5075. 2008. View Article : Google Scholar : PubMed/NCBI
19	Saraon P and Jarvi K: Molecular alterations during progression of prostate cancer to androgen independence. Clin Chem. 57:1366–1375. 2011. View Article : Google Scholar : PubMed/NCBI
20	Schröder FH: Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms. Eur Urol. 53:1129–1173. 2008. View Article : Google Scholar : PubMed/NCBI
21	Aoi J, Endo M, Kadomatsu T, et al: Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress. Mol Cancer Res. 12:239–249. 2014. View Article : Google Scholar
22	Endo M, Yamamoto Y, Masuda T, et al: Serum ANGPTL2 levels reflect clinical features of breast cancer patients: implications for the pathogenesis of breast cancer metastasis. Int J Biol Markers. 29:239–245. 2014.
23	Odagiri H, Kadomatsu T, Endo M, et al: The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin α5β1, p38 MAPK and matrix metalloproteinases. Sci Signal. 7:ra72014. View Article : Google Scholar
24	Kuo TC, Tan CT, Chang YW, et al: Angiopoetin-like protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin Invest. 123:1082–1095. 2013. View Article : Google Scholar : PubMed/NCBI
25	Tan MJ, Teo Z, Sng MK, et al: Emerging Roles of Angiopoietin-like 4 in human cancer. Mol Cancer Res. 10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
26	Li H, Ge C, Zhao F, et al: Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma. Hepatology. 54:910–919. 2011. View Article : Google Scholar : PubMed/NCBI
27	Okochi-Takada E, Hattori N, Tsukamoto T, et al: ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis. Oncogene. 24:2273–2278. 2014. View Article : Google Scholar